Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
GFRA1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
CCDC172 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PNLIPRP3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PNLIP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PNLIPRP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PNLIPRP2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
C10orf82 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HSPA12A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ATRNL1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TRUB1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FAM160B1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on